Century Therapeutics is a biotechnology company developing allogeneic, iPSC-derived cell therapies for autoimmune diseases and cancer. Key programs include CNTY-813 (beta islet therapy for type 1 diabetes), CNTY-308 (CD19-targeted CAR-iT cell therapy for B-cell-mediated diseases), and CNTY-101 (CD19 CAR-iNK cell therapy for autoimmune diseases). The company uses iPSC technology, CRISPR-mediated gene editing, and proprietary Allo-Evasion technology to create off-the-shelf cell therapies with scalable manufacturing capabilities.
expected 2026-12-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001104659-26-026759 | EDGAR | 100K words |
| 2025-03-19 | 2024-12-31 | 0001558370-25-003299 | EDGAR | 101K words |
| 2024-03-14 | 2023-12-31 | 0001558370-24-003165 | EDGAR | 110K words |
| 2023-03-16 | 2022-12-31 | 0001558370-23-003962 | EDGAR | 109K words |
| 2022-03-17 | 2021-12-31 | 0001558370-22-003867 | EDGAR | 106K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-12 | 2026-06-30 | 0001104659-26-094523 | EDGAR | 25K words |
| 2025-11-13 | 2025-09-30 | 0001104659-25-110851 | EDGAR | 27K words |
| 2025-08-14 | 2025-06-30 | 0001558370-25-011575 | EDGAR | 27K words |
| 2025-05-15 | 2025-03-31 | 0001558370-25-007885 | EDGAR | 24K words |
| 2024-11-05 | 2024-09-30 | 0001558370-24-014345 | EDGAR | 29K words |
| 2024-08-08 | 2024-06-30 | 0001558370-24-011467 | EDGAR | 29K words |
| 2024-05-09 | 2024-03-31 | 0001558370-24-007469 | EDGAR | 24K words |
| 2023-11-09 | 2023-09-30 | 0001558370-23-018408 | EDGAR | 29K words |
| 2023-08-09 | 2023-06-30 | 0001558370-23-014082 | EDGAR | 28K words |
| 2023-05-11 | 2023-03-31 | 0001558370-23-009262 | EDGAR | 26K words |
| 2022-11-10 | 2022-09-30 | 0001558370-22-017287 | EDGAR | 33K words |
| 2022-08-11 | 2022-06-30 | 0001558370-22-013181 | EDGAR | 32K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-10-02 | 0001104659-26-113055 | EDGAR | 3K words |
| 2026-09-09 | 0001104659-26-106312 | EDGAR | 1K words |
| 2026-08-12 | 0001104659-26-094533 | EDGAR | 3K words |
| 2026-03-26 | 0001104659-26-035256 | EDGAR | 1K words |
| 2026-03-12 | 0001104659-26-026761 | EDGAR | 3K words |
| 2026-01-23 | 0001104659-26-006236 | EDGAR | 1K words |
| 2026-01-12 | 0001104659-26-002748 | EDGAR | 5K words |
| 2026-01-08 | 0001104659-26-001952 | EDGAR | 4K words |
| 2025-12-29 | 0001104659-25-124836 | EDGAR | 1K words |
| 2025-12-12 | 0001104659-25-120654 | EDGAR | 4K words |
107 total filings indexed. 80 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001850119 |
| Ticker | IPSC |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.centurytx.com |
| Listed | 2021-06-18 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/IPSC (~200 tokens, structured JSON with cryptographic provenance)